ReviewFrontiers in immunology2026

Immunotherapy of membranous nephropathy: strategic evolution from CD20 monoclonal antibodies to future vaccines.

Kena Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.